chevron_leftBack
Shenzhen Neptunus Interlong Bio-technique Company Ltd.
8329
0.1250HKD
0.8%
0.0159 USD
As of 9 June 2026, Shenzhen Neptunus Interlong Bio-technique Company Ltd. has a market cap of $26.55M USD, ranking #35096 globally and #952 in Hong Kong.
It ranks #3168 in the Healthcare sector, and #1071 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$26.55MUSD
208.07M HKD
Enterprise Value
$15.22MUSD
119.26M HKD
Revenue (TTM)
$138.02MUSD
1.08B HKD
EBITDA (TTM)
$6.97MUSD
54.63M HKD
Net Income (TTM)
-$5.78MUSD
-45.33M HKD
EBITDA Margin
5.1%
Profit Margin
-4.2%
PS Ratio
0.2
PB Ratio
0.3
EV/EBITDA
2.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1,382
Founded
2002
Website
interlong.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.8% | -3.1% | -4.6% | -24% | -12% | -64% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
8329
深圳市海王英特龙生物技术股份有限公司
ISIN: CNE100000775
Shares Out.:
Shares Outstanding:
426.0M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.1250 HKD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Shenzhen Neptunus Interlong Bio-technique Company Ltd.
Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. It also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business. Shenzhen Neptunus Interlong Bio-technique Company Limited was incorporated in 2002 and is based in Quarry Bay, Hong Kong. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RGC
|
$14.32B
54K%
|
-
|
|
SHEK: 1177
|
$12.44B
47K%
97.51B HKD
|
37.8
|
|
SHEK: 3696
|
$4.7B
18K%
36.81B HKD
|
-
|
|
SHEK: 3320
|
$4.2B
16K%
32.92B HKD
|
7.3
|
|
SHEK: 512
|
$2.86B
11K%
22.45B HKD
|
18.1
|
|
|
$2.4B
9K%
18.78B HKD
|
7.7
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
3M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
2M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
1M%
|
97.4
|
|
SIX: RO
|
$322.98B
1M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.68B
1M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.9B
1M%
218.9B CHF
|
20.5
|
chevron_leftBack